Skip to main content
. Author manuscript; available in PMC: 2016 Nov 5.
Published in final edited form as: J Biomed Inform. 2016 Mar 10;60:431–445. doi: 10.1016/j.jbi.2016.03.001

Table 1.

Distribution of gender, stage and tumor type in training and validation set (data set is obtained from TCGA)

Training Validating P-value
Gender Female 238 208 0.10
Male 318 343
Missing 6 11
Stage Stage I 296 277 0.15
Stage II 144 160
Stage III 102 87
Stage IV 13 23
Missing 7 15
Tumor Adenocarcinoma 286 285 1.00
Squamous Carcinoma 276 277
Total 562 562